St. Jude Confirms 5-Year Data from FAME Trial Further Confirms Sustained, Long Term Benefit of FFR-Guided PCI
August 30, 2015 at 11:20 AM EDT
St. Jude Medical, Inc.(NYSE: STJ) today announced that five year results from the landmark FAME trial ...